At a glance
- Originator Abbott Laboratories
- Class Amides; Antihyperlipidaemics; Dicarboxylic acids
- Mechanism of Action Squalene synthase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Hypercholesterolaemia